RCT of Gastric ESD With or Without Epineprhine Added Solution

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

January 31, 2023

Conditions
Gastric NeoplasmEarly Gastric Cancer
Interventions
PROCEDURE

Endoscopic submucosal dissection

Endoscopic submucosal dissection

DRUG

Epinephrine

Epinephrine

Trial Locations (7)

Unknown

The Chinese University of Hong Kong, Hong Kong

Ishikawa Prefecture Central Hospital, Ishikawa

Kyoto 2nd Red Cross Hospital, Kyoto

Osaka International Cancer Institute, Osaka

Shizuoka Cancer Center, Shizuoka

Changi General Hospital, Singapore

Kosin University Gospel Hospital, Busan

All Listed Sponsors
collaborator

Osaka International Cancer Institute

UNKNOWN

collaborator

Fukuoka University

OTHER

collaborator

Changi General Hospital

OTHER

collaborator

Kyoto 2nd Red Cross Hospital

UNKNOWN

collaborator

Ishikawa Prefectural Central Hospital

UNKNOWN

collaborator

Kosin University Gospel Hospital

OTHER

collaborator

Machida General Hospital

UNKNOWN

collaborator

Nara City Hospital

UNKNOWN

collaborator

Wakayama Red Cross Hospital

UNKNOWN

collaborator

JCHO Osaka Hospital

UNKNOWN

collaborator

Sapporo Kinentou hospital

UNKNOWN

collaborator

Japan Community Healthcare Organization Osaka Hospital

UNKNOWN

lead

Chinese University of Hong Kong

OTHER

NCT04032119 - RCT of Gastric ESD With or Without Epineprhine Added Solution | Biotech Hunter | Biotech Hunter